Evidence map›Paper›PMID 41761678›Full record

ArticleStatistics in medicine2026

Estimands and Doubly Robust Estimation for Cluster-Randomized Trials With Survival Outcomes.

Xi Fang, Bingkai Wang, Liangyuan Hu, Fan Li

Abstract read
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xi FangDepartment of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-6692-5730
Bingkai WangDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Liangyuan HuDepartment of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, USA.
Fan LiDepartment of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-6183-1893

Funding

Randomized Trial of a Multifactorial Fall Injury Prevention Strategy-SupplementU01AG048270 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI BHASIN, SHALENDER, GILL, THOMAS MICHAEL · 2014 to 2019
$34.8M
New win methods for addressing multiple and composite outcomes in cluster-randomized trialsR01HL178513 · NHLBI · YALE UNIVERSITY · PI Fan Li · 2025 to 2026
$1.4M
Improving the design and statistical analysis of cluster-randomized trials on tropical infectious diseasesR00AI173395 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, BINGKAI · 2024 to 2025
$497k
National Institute of Allergy and Infectious Diseases R00AI173395NHLBI NIH HHS 1R01HL178513-01NHLBI NIH HHS R01 HL178513NIAID NIH HHS R00 AI173395NIA NIH HHS U01 AG048270Patient-Centered Outcomes Research Institute ME-2021C2-23685Patient-Centered Outcomes Research Institute ME-2022C2-27676
6 · The paper itself

Abstract

Cluster-randomized trials (CRTs) are experimental designs where groups or clusters of participants, rather than the individual participants themselves, are randomized to intervention groups. Analyzing CRT requires distinguishing between treatment effects at the cluster level and the individual level, which requires a clear definition of the estimands under a causal inference framework. For analyzing survival outcomes, it is common to assess the treatment effect by comparing survival functions or restricted mean survival times (RMSTs) between treatment groups. In this article, we formally characterize cluster-level and individual-level treatment effect estimands with right-censored survival outcomes in CRTs and propose doubly robust estimators for targeting such estimands. Under censoring dependent on baseline covariates, our estimators ensure consistency when either the censoring model or the outcome model is correctly specified, but not necessarily both. We explore different modeling options for the censoring and outcome models to estimate the censoring and survival distributions, and investigate a deletion-based jackknife method for variance and interval estimation. Extensive simulations demonstrate that the proposed methods perform adequately in finite samples. Finally, we illustrate our method by analyzing a completed CRT with survival endpoints.

Indexed as

Randomized Controlled Trials as TopicCluster AnalysisComputer SimulationHumansModels, StatisticalSurvival AnalysisCluster‐randomized trialdouble robustnessestimandsinformative cluster sizerestricted mean survival timesurvival function

Identifiers

PMID41761678
PMCPMC13399588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.